Skinny Labels, Second Medical Use Patents and the Nigerian Gap: What Hikma v Amarin Means for Local Practice

Every so often a patent dispute over a single drug ends up reshaping the rules for an entire industry. Back in June, the US Supreme Court delivered one of those decisions. Although the case itself is American, the question underneath…










